GENPRU 2
Capital
GENPRU 2.1
Calculation of capital resources requirements
- 31/12/2006
Application
GENPRU 2.1.1A
See Notes
- 01/01/2014
GENPRU 2.1.2
See Notes
- 01/04/2013
GENPRU 2.1.3
See Notes
- 01/04/2013
GENPRU 2.1.4
See Notes
- 01/04/2013
GENPRU 2.1.5
See Notes
- 01/04/2013
Purpose
GENPRU 2.1.6
See Notes
- 01/04/2013
GENPRU 2.1.7
See Notes
- 01/04/2013
GENPRU 2.1.8A
See Notes
- 01/01/2014
Monitoring requirements
GENPRU 2.1.9
See Notes
- 01/04/2013
GENPRU 2.1.10
See Notes
- 01/04/2013
GENPRU 2.1.11
See Notes
- 01/04/2013
Additional capital requirements
GENPRU 2.1.12
See Notes
- 01/04/2013
Main requirement: Insurers
GENPRU 2.1.13
See Notes
- 01/04/2013
GENPRU 2.1.14
See Notes
- 01/04/2013
GENPRU 2.1.15
See Notes
- 01/04/2013
GENPRU 2.1.16
See Notes
- 01/04/2013
Calculation of the CRR for an insurer
GENPRU 2.1.17
See Notes
- 01/04/2013
GENPRU 2.1.18
See Notes
- 01/04/2013
GENPRU 2.1.19
See Notes
- 01/04/2013
GENPRU 2.1.20
See Notes
- 19/06/2014
GENPRU 2.1.21
See Notes
- 01/04/2013
GENPRU 2.1.22
See Notes
- 01/04/2013
GENPRU 2.1.23
See Notes
- 01/04/2013
Calculation of the MCR (Insurer only)
GENPRU 2.1.24
See Notes
- 01/04/2013
GENPRU 2.1.24A
See Notes
- 01/04/2013
GENPRU 2.1.25
See Notes
- 01/04/2013
GENPRU 2.1.26
See Notes
- 01/04/2013
GENPRU 2.1.27
See Notes
- 01/04/2013
GENPRU 2.1.28
See Notes
- 01/04/2013
Calculation of the base capital resources requirement for an insurer
GENPRU 2.1.29
See Notes
- 01/04/2013
Table: Base capital resources requirement for an insurer
GENPRU 2.1.30
See Notes
This table belongs to GENPRU 2.1.29 R
Firm category | Amount: Currency equivalent of | |
General insurance business | ||
Liability insurer (classes 10-15) | Directive mutual | €2.775 million |
Non-directive insurer | €350,000 | |
Other (including mixed insurer but excluding pure reinsurer) | €3.7 million | |
Other insurer | Directive mutual | €1.875 million |
Non-directive insurer (classes 1 to 8, 16 or 18) | €260,000 | |
Non-directive insurer (classes 9 or 17) | €175,000 | |
Mixed insurer | €3.7 million | |
Other (excluding pure reinsurer) | €2.5 million | |
Long-term insurance business | ||
Mutual | Directive | €2.775 million |
Non-directive mutual | €700,000 | |
Any other insurer (including mixed insurer but excluding pure reinsurer) | €3.7 million | |
All business (general insurance business and long-term insurance business) | ||
Pure reinsurer excluding captive reinsurer | €3.7 million | |
Captive reinsurer | €1.2 million |
- 01/04/2013
GENPRU 2.1.31
See Notes
- 01/04/2013
GENPRU 2.1.32
See Notes
- 01/04/2013
GENPRU 2.1.33
See Notes
- 01/04/2013
Calculation of the general insurance capital requirement (Insurer only)
GENPRU 2.1.34
See Notes
- 01/04/2013
GENPRU 2.1.35
See Notes
- 01/04/2013
Calculation of the long-term insurance capital requirement (Insurer only)
GENPRU 2.1.36
See Notes
- 01/04/2013
GENPRU 2.1.37
See Notes
- 01/04/2013
Calculation of the ECR (Insurer only)
GENPRU 2.1.38
See Notes
- 01/04/2013
GENPRU 2.1.39
See Notes
- 01/04/2013
GENPRU 2.2
Capital resources
- 31/12/2006
Application
GENPRU 2.2.1A
See Notes
- 01/01/2014
Purpose
GENPRU 2.2.2
See Notes
- 01/04/2013
GENPRU 2.2.3
See Notes
- 01/04/2013
Principles underlying the definition of capital resources
GENPRU 2.2.8
See Notes
- 01/04/2013
Tier one capital
GENPRU 2.2.9
See Notes
- 01/04/2013
GENPRU 2.2.10
See Notes
- 01/04/2013
Upper and lower tier two capital
GENPRU 2.2.11
See Notes
- 01/04/2013
Tier three capital
GENPRU 2.2.12
See Notes
- 01/04/2013
Non-standard capital instruments
GENPRU 2.2.13
See Notes
- 01/04/2013
Deductions from capital
GENPRU 2.2.14
See Notes
- 01/01/2014
GENPRU 2.2.16
See Notes
- 01/04/2013
Calculation of capital resources: Insurers
GENPRU 2.2.22
See Notes
- 01/01/2014
Table: Approaches to calculating capital resources
GENPRU 2.2.23
See Notes
This table belongs to GENPRU 2.2.22 G
Liabilities | Assets | ||
Borrowings | 100 | Admissible assets | 350 |
Ordinary shares | 200 | Intangible assets | 100 |
Profit and loss account and other reserves | 100 | Other inadmissible assets | 100 |
Perpetual subordinated debt | 150 | ||
Total | 550 | Total | 550 |
Calculation of capital resources: eligible assets less foreseeable liabilities | |||
Total assets | 550 | ||
less intangible assets | (100) | ||
less inadmissible assets | (100) | ||
less liabilities (borrowings) | (100) | ||
Capital resources | 250 | ||
Calculation of capital resources: components of capital | |||
Ordinary shares | 200 | ||
Profit and loss account and other reserves | 100 | ||
Perpetual subordinated debt | 150 | ||
less intangible assets | (100) | ||
less inadmissible assets | (100) | ||
Capital resources | 250 |
- 01/04/2013
Limits on the use of different forms of capital: General
GENPRU 2.2.24
See Notes
- 01/04/2013
Limits on the use of different forms of capital: Use of higher tier capital in lower tiers
GENPRU 2.2.25
See Notes
- 01/04/2013
GENPRU 2.2.26
See Notes
- 01/04/2013
GENPRU 2.2.26A
See Notes
- 01/04/2013
Limits on the use of different forms of capital: Limits relating to tier one capital applicable to insurers
GENPRU 2.2.29
See Notes
- 01/04/2013
GENPRU 2.2.30
See Notes
- 01/04/2013
Limits on the use of different forms of capital: Limits relating to tier one capital: Purpose of the requirements
GENPRU 2.2.31
See Notes
- 01/04/2013
Limits on the use of different forms of capital: Insurers
GENPRU 2.2.32
See Notes
- 01/04/2013
GENPRU 2.2.33
See Notes
- 01/04/2013
GENPRU 2.2.34
See Notes
- 01/04/2013
GENPRU 2.2.34A
See Notes
- 01/04/2013
GENPRU 2.2.35
See Notes
- 01/04/2013
GENPRU 2.2.36
See Notes
- 01/04/2013
GENPRU 2.2.37
See Notes
- 01/04/2013
GENPRU 2.2.38
See Notes
- 01/04/2013
GENPRU 2.2.39
See Notes
- 01/04/2013
GENPRU 2.2.40
See Notes
- 01/04/2013
GENPRU 2.2.41
See Notes
- 01/04/2013
Notification of issuance of capital instruments
GENPRU 2.2.61A
See Notes
- 01/04/2013
GENPRU 2.2.61B
See Notes
- 01/04/2013
GENPRU 2.2.61C
See Notes
- 01/04/2013
GENPRU 2.2.61D
See Notes
- 01/04/2013
GENPRU 2.2.61E
See Notes
- 01/04/2013
GENPRU 2.2.61F
See Notes
- 01/04/2013
GENPRU 2.2.61G
See Notes
- 01/04/2013
GENPRU 2.2.61H
See Notes
- 01/04/2013
Tier one capital: General
GENPRU 2.2.62
See Notes
- 01/04/2013
GENPRU 2.2.63
See Notes
- 01/04/2013
General conditions for eligibility as tier one capital
GENPRU 2.2.64
See Notes
- 01/04/2013
GENPRU 2.2.65
See Notes
- 01/04/2013
Guidance on certain of the general conditions for eligibility as tier one capital
GENPRU 2.2.66
See Notes
- 01/04/2013
GENPRU 2.2.67
See Notes
- 01/04/2013
GENPRU 2.2.67A
See Notes
- 01/04/2013
GENPRU 2.2.68
See Notes
- 01/04/2013
GENPRU 2.2.69
See Notes
- 01/04/2013
Redemption of tier one instruments
GENPRU 2.2.70
See Notes
- 01/04/2013
GENPRU 2.2.71
See Notes
- 01/04/2013
GENPRU 2.2.72
See Notes
- 01/04/2013
GENPRU 2.2.73
See Notes
- 01/04/2013
GENPRU 2.2.74
See Notes
- 01/04/2013
GENPRU 2.2.74A
See Notes
- 01/04/2013
GENPRU 2.2.75
See Notes
- 01/04/2013
Step-ups and redeemable tier one instruments: Insurer only
GENPRU 2.2.76
See Notes
- 01/04/2013
Meaning of redemption
GENPRU 2.2.77
See Notes
- 01/04/2013
GENPRU 2.2.78
See Notes
- 01/04/2013
GENPRU 2.2.79
See Notes
- 01/04/2013
Loss absorption
GENPRU 2.2.80
See Notes
- 01/01/2014
GENPRU 2.2.81
See Notes
- 01/04/2013
GENPRU 2.2.82
See Notes
- 01/04/2013
Core tier one capital: permanent share capital
GENPRU 2.2.83
See Notes
- 01/01/2014
Core tier one capital: additional information
GENPRU 2.2.84
See Notes
- 01/01/2014
GENPRU 2.2.84A
See Notes
- 01/04/2013
Core tier one capital: profit and loss account and other reserves: Losses
GENPRU 2.2.85A
See Notes
- 01/01/2014
Core tier one capital: profit and loss account and other reserves: Dividends
GENPRU 2.2.87
See Notes
- 01/04/2013
GENPRU 2.2.87A
See Notes
- 01/04/2013
Core tier one capital: profit and loss account and other reserves: Capital contributions
GENPRU 2.2.88
See Notes
- 01/04/2013
GENPRU 2.2.89
See Notes
- 01/04/2013
Core tier one capital: profit and loss account and other reserves: Valuation
GENPRU 2.2.91
See Notes
- 01/04/2013
Core tier one capital: Share premium account
GENPRU 2.2.101
See Notes
- 01/04/2013
Core tier one capital: externally verified interim net profits
GENPRU 2.2.102
See Notes
- 01/04/2013
GENPRU 2.2.103
See Notes
- 01/04/2013
Core tier one capital: valuation differences (insurer only)
GENPRU 2.2.104
See Notes
- 01/04/2013
GENPRU 2.2.105
See Notes
- 01/04/2013
GENPRU 2.2.106
See Notes
- 01/04/2013
GENPRU 2.2.107
See Notes
- 01/04/2013
Core tier one capital: fund for future appropriations (insurer only)
GENPRU 2.2.108
See Notes
- 01/04/2013
Other tier one capital: perpetual non-cumulative preference shares (insurer only)
GENPRU 2.2.109
See Notes
- 01/04/2013
GENPRU 2.2.110
See Notes
- 01/04/2013
Other tier one capital: innovative tier one capital: general (insurer only)
GENPRU 2.2.113
See Notes
- 01/04/2013
Other tier one capital: innovative tier one capital: redemption (insurer only)
GENPRU 2.2.114
See Notes
- 01/04/2013
GENPRU 2.2.115
See Notes
- 01/04/2013
Other tier one capital: loss absorption
GENPRU 2.2.116
See Notes
- 01/04/2013
GENPRU 2.2.117
See Notes
- 01/04/2013
GENPRU 2.2.118
See Notes
- 01/04/2013
GENPRU 2.2.119
See Notes
- 01/04/2013
Other tier one capital: innovative tier one capital: coupons (insurer only)
GENPRU 2.2.120
See Notes
- 01/04/2013
Other tier one capital: innovative tier one capital: step-ups (insurer only)
GENPRU 2.2.121
See Notes
- 01/04/2013
GENPRU 2.2.122
See Notes
- 01/04/2013
Tier one capital: Conversion ratio
GENPRU 2.2.138
See Notes
- 01/04/2013
GENPRU 2.2.139
See Notes
- 01/04/2013
GENPRU 2.2.140
See Notes
- 01/04/2013
GENPRU 2.2.141
See Notes
- 01/04/2013
GENPRU 2.2.142
See Notes
- 01/04/2013
GENPRU 2.2.143
See Notes
- 01/04/2013
GENPRU 2.2.144
See Notes
- 01/04/2013
Tier one capital: Requirement to have sufficient unissued stock
GENPRU 2.2.145
See Notes
- 01/04/2013
Step-ups: calculating the size of a step-up
GENPRU 2.2.146
See Notes
- 01/04/2013
Step-ups: Limits on the amount of step-ups on tier one and two capital
GENPRU 2.2.147
See Notes
- 01/04/2013
GENPRU 2.2.148
See Notes
- 01/04/2013
GENPRU 2.2.149
See Notes
- 01/04/2013
GENPRU 2.2.150
See Notes
- 01/04/2013
GENPRU 2.2.151
See Notes
- 01/04/2013
GENPRU 2.2.152
See Notes
- 01/04/2013
GENPRU 2.2.153
See Notes
- 01/04/2013
GENPRU 2.2.154
See Notes
- 01/04/2013
Deductions from tier one: Intangible assets
GENPRU 2.2.155
See Notes
- 01/04/2013
GENPRU 2.2.156A
See Notes
- 01/01/2014
Tier two capital: General
GENPRU 2.2.157
See Notes
- 01/04/2013
GENPRU 2.2.158
See Notes
- 01/04/2013
General conditions for eligibility as tier two capital instruments
GENPRU 2.2.159
See Notes
- 01/04/2013
General conditions for eligibility as tier two capital instruments: Additional remedies
GENPRU 2.2.161
See Notes
- 01/04/2013
GENPRU 2.2.162
See Notes
- 01/04/2013
General conditions for eligibility as tier two capital instruments: Alternative governing laws
GENPRU 2.2.163
See Notes
- 01/04/2013
General conditions for eligibility as tier two capital instruments: Standard form documentation
GENPRU 2.2.164
See Notes
- 01/04/2013
Guidance on the general conditions for eligibility as tier two capital instruments
GENPRU 2.2.165
See Notes
- 01/04/2013
GENPRU 2.2.166
See Notes
- 01/04/2013
GENPRU 2.2.167
See Notes
- 01/04/2013
GENPRU 2.2.168
See Notes
- 01/04/2013
Tier two capital instruments: Connected transactions
GENPRU 2.2.169
See Notes
- 01/04/2013
GENPRU 2.2.170
See Notes
- 01/04/2013
Amendment of tier two instruments
GENPRU 2.2.171
See Notes
- 01/04/2013
Redemption of tier two instruments
GENPRU 2.2.172
See Notes
- 01/04/2013
GENPRU 2.2.173
See Notes
- 01/04/2013
GENPRU 2.2.174
See Notes
- 01/04/2013
Tier two capital: step-ups
GENPRU 2.2.175
See Notes
- 01/04/2013
Upper tier two capital: General
GENPRU 2.2.176
See Notes
- 01/04/2013
GENPRU 2.2.177
See Notes
- 01/04/2013
GENPRU 2.2.178
See Notes
- 01/04/2013
GENPRU 2.2.179
See Notes
- 01/04/2013
Upper tier two capital: Loss absorption
GENPRU 2.2.180
See Notes
- 01/04/2013
Upper tier two capital: Legal opinions
GENPRU 2.2.181
See Notes
- 01/04/2013
Upper tier two capital: Guidance
GENPRU 2.2.182
See Notes
- 01/04/2013
GENPRU 2.2.183
See Notes
- 01/04/2013
GENPRU 2.2.184
See Notes
- 01/04/2013
Lower tier two capital
GENPRU 2.2.194
See Notes
- 01/04/2013
GENPRU 2.2.195
See Notes
- 01/04/2013
GENPRU 2.2.196
See Notes
- 01/04/2013
GENPRU 2.2.197
See Notes
- 01/04/2013
The effect of swaps on debt capital
GENPRU 2.2.198
See Notes
- 01/04/2013
GENPRU 2.2.199
See Notes
- 01/04/2013
GENPRU 2.2.200
See Notes
- 01/04/2013
GENPRU 2.2.201
See Notes
- 01/04/2013
Deductions from total capital: Inadmissible assets (insurers only)
GENPRU 2.2.250
See Notes
- 01/04/2013
GENPRU 2.2.251
See Notes
- 01/04/2013
GENPRU 2.2.252
See Notes
- 01/04/2013
GENPRU 2.2.253
See Notes
- 01/04/2013
Deductions from total capital: Adjustments for related undertakings
GENPRU 2.2.254
See Notes
- 01/04/2013
GENPRU 2.2.255
See Notes
- 01/04/2013
GENPRU 2.2.256
See Notes
- 01/04/2013
GENPRU 2.2.257
See Notes
- 01/04/2013
GENPRU 2.2.258
See Notes
- 01/04/2013
Other capital resources: Unpaid share capital or initial funds and calls for supplementary contributions (Insurer only)
GENPRU 2.2.266
See Notes
- 01/04/2013
GENPRU 2.2.267
See Notes
- 01/04/2013
GENPRU 2.2.268
See Notes
- 01/04/2013
GENPRU 2.2.269
See Notes
- 01/04/2013
Other requirements: insurers carrying on with-profits business (Insurer only)
GENPRU 2.2.270
See Notes
- 01/04/2013
GENPRU 2.2.270A
See Notes
- 01/04/2013
GENPRU 2.2.271
See Notes
- 01/04/2013
GENPRU 2.2.272
See Notes
- 01/04/2013
GENPRU 2.2.273
See Notes
- 01/04/2013
GENPRU 2.2.274
See Notes
- 01/04/2013
GENPRU 2.2.275
See Notes
- 01/04/2013
GENPRU 2.3
Application of GENPRU 2 to Lloyd's
- 31/12/2006
Application of GENPRU 2.1
GENPRU 2.3.1
See Notes
- 01/04/2013
GENPRU 2.3.2
See Notes
- 01/04/2013
GENPRU 2.3.3
See Notes
- 01/04/2013
GENPRU 2.3.4
See Notes
- 01/04/2013
Calculation of the MCR
GENPRU 2.3.5
See Notes
- 01/04/2013
GENPRU 2.3.6
See Notes
- 01/04/2013
GENPRU 2.3.7
See Notes
- 01/04/2013
GENPRU 2.3.8
See Notes
- 01/04/2013
Calculation of the base capital resources requirement
GENPRU 2.3.9
See Notes
- 01/04/2013
Calculation of the general insurance capital requirement
GENPRU 2.3.10
See Notes
- 01/04/2013
GENPRU 2.3.11
See Notes
- 01/04/2013
GENPRU 2.3.12
See Notes
- 01/04/2013
GENPRU 2.3.13
See Notes
- 01/04/2013
GENPRU 2.3.14
See Notes
- 01/04/2013
GENPRU 2.3.15
See Notes
- 01/04/2013
Application of GENPRU 2.2
GENPRU 2.3.16
See Notes
- 01/04/2013
GENPRU 2.3.17
See Notes
- 01/04/2013
GENPRU 2.3.18
See Notes
- 01/04/2013
GENPRU 2.3.19
See Notes
- 01/04/2013
GENPRU 2.3.20
See Notes
- 01/04/2013
GENPRU 2.3.21
See Notes
- 01/04/2013
Calculation of capital resources
GENPRU 2.3.22
See Notes
- 01/04/2013
GENPRU 2.3.23
See Notes
- 01/04/2013
GENPRU 2.3.24
See Notes
- 01/04/2013
GENPRU 2.3.25
See Notes
- 01/04/2013
GENPRU 2.3.26
See Notes
- 01/04/2013
GENPRU 2.3.27
See Notes
- 01/04/2013
GENPRU 2.3.28
See Notes
- 01/04/2013
GENPRU 2.3.29
See Notes
- 01/04/2013
GENPRU 2.3.30
See Notes
- 01/04/2013
Characteristics of tier one capital
GENPRU 2.3.31
See Notes
- 01/04/2013
Adjustments for related undertakings
GENPRU 2.3.32
See Notes
- 01/04/2013
GENPRU 2.3.33
See Notes
- 01/04/2013
Modification of GENPRU 2 Annex 7R for Lloyd's
GENPRU 2.3.34
See Notes
- 01/04/2013
GENPRU 2.3.35
See Notes
- 01/04/2013
GENPRU 2 Annex 1
Capital resources table for an insurer
- 31/12/2006
See Notes
Capital resources calculation for an insurer | |||
Type of capital | Related text | Stage | |
Core tier one capital | (A) | ||
Permanent share capital | GENPRU 2.2.83 R | ||
Profit and loss account and other reserves (taking into account interim net losses) | GENPRU 2.2.85A R; GENPRU 2.2.87 R to GENPRU 2.2.88 R | ||
Share premium account | GENPRU 2.2.101 R | ||
Externally verified interim net profits | GENPRU 2.2.102 R | ||
Positive valuation differences | GENPRU 2.2.105 R | ||
Fund for future appropriations | GENPRU 2.2.108 R | ||
Perpetual non-cumulative preference shares | (B) | ||
Perpetual non-cumulative preference shares | GENPRU 2.2.109 R | ||
Innovative tier one capital | (C) | ||
Innovative tier one instruments | GENPRU 2.2.113 R to GENPRU 2.2.121 R | ||
Total tier one capital before deductions = A+B+C | (D) | ||
Deductions from tier one capital | (E) | ||
Investments in own shares | None | ||
Intangible assets | GENPRU 2.2.155 R | ||
Amounts deducted from technical provisions for discounting and other negative valuation differences | GENPRU 2.2.105 R to GENPRU 2.2.107 R | ||
Total tier one capital after deductions = D-E | (F) | ||
Upper tier two capital | (G) | ||
Perpetual cumulative preference shares | GENPRU 2.2.159 R to GENPRU 2.2.181 R | ||
Perpetual subordinated debt | See previous entry | ||
Perpetual subordinated securities | See previous entry | ||
Lower tier two capital | (H) | ||
Fixed term preference shares | GENPRU 2.2.159 R to GENPRU 2.2.175 G; GENPRU 2.2.194 R to GENPRU 2.2.196 R | ||
Long term subordinated debt | See previous entry | ||
Fixed term subordinated securities | See previous entry | ||
Total tier two capital = G+H | (I) | ||
Positive adjustments for related undertakings | (J) | ||
Related undertakings that are regulated related undertakings (other than insurance undertakings) | GENPRU 2.2.256 R | ||
Total capital after positive adjustments for insurance undertakings but before deductions = F + I + J | (K) | ||
Deductions from total capital | (L) | ||
Inadmissible assets | GENPRU 2.2.250 R to GENPRU 2.2.251 R; GENPRU 2 Annex 7 | ||
Assets in excess of market risk and counterparty limits | INSPRU 2.1.22 R | ||
Related undertakings that are ancillary services undertakings | GENPRU 2.2.255 R | ||
Negative adjustments for Related undertakings that are regulated related undertakings (other than insurance undertakings) | GENPRU 2.2.256 R | ||
Total capital after deductions = K - L | (M) | ||
Other capital resources* | (N) | ||
Unpaid share capital or, in the case of a mutual, unpaid initial funds and calls for supplementary contributions | GENPRU 2.2.266 G to GENPRU 2.2.269 G | ||
Implicit items | GENPRU 2 Annex 8 | ||
Total capital resources after deductions = M + N | (O) | ||
* Items in section (N) of the table can be included in capital resources if subject to a waiver under section 138A of the Act. | |||
Note: Where the table refers to related text, it is necessary to refer to that text in order to understand fully what is included in the descriptions of capital items and deductions set out in the table. |
- 01/01/2014
GENPRU 2 Annex 7
Admissible assets in insurance
- 31/12/2006
See Notes
(1) | (A) | Investments that are, or amounts owed arising from the disposal of: | ||
(a) | debt securities, bonds and other money and capital market instruments; | |||
(b) | loans; | |||
(c) | shares and other variable yield participations; | |||
(d) | units in: | |||
(i) | collective investment schemes falling within the UCITS Directive; | |||
(ii) | non-UCITS retail schemes; | |||
(iii) | recognised schemes; and | |||
(iv) | any other collective investment scheme where the insurer's investment in the scheme is sufficiently small to be consistent with a prudent overall investment strategy, having regard to the investment policy of the scheme and the information available to the insurer to enable it to monitor the investment risk being taken by the scheme | |||
(e) | land, buildings and immovable property rights; | |||
(f) | an approved derivative or quasi-derivative transaction that satisfies the conditions in INSPRU 3.2.5 R or an approved stock lending transaction that satisfies the conditions in INSPRU 3.2.36 R. | |||
(B) | Debts and claims | |||
(a) | debts owed by reinsurers, including reinsurers' shares of technical provisions (but excluding amounts recoverable from an ISPV*); | |||
(b) | deposits with and debts owed by ceding undertakings; | |||
(c) | debts owed by policyholders and intermediaries arising out of direct and reinsurance operations (except where overdue for more than 3 months and other than commission prepaid to agents or intermediaries); | |||
(d) | for general insurance business only, claims arising out of salvage and subrogation; | |||
(e) | for long-term insurance business only, advances secured on, and not exceeding the surrender value of, long-term insurance contracts issued by the insurer; | |||
(f) | tax recoveries; | |||
(g) | claims against compensation funds. | |||
(C) | Other assets | |||
(a) | tangible fixed assets, other than land and buildings; | |||
(b) | cash at bank and in hand, deposits with credit institutions and any other bodies authorised to receive deposits; | |||
(c) | for general insurance business only, deferred acquisition costs; | |||
(d) | accrued interest and rent, other accrued income and prepayments; | |||
(e) | for long-term insurance business only, reversionary interests. | |||
* | An insurer may treat amounts recoverable from an ISPV as an admissible asset if it obtains a waiver under section 138A of the Act. The conditions that will need to be met, in addition to the statutory tests under section 138A(4) of the Act, before the appropriate regulator will consider granting such a waiver are set out in INSPRU 1.6.13 G to INSPRU 1.6.18 G. | |||
(2) | Subject to paragraph (3) belowa unit in a collective investment scheme is only admissible for the purposes of paragraph (1) above if it falls within paragraph (1)(A)(d), notwithstanding that it may also fall into one or more other categories in paragraph (1). | |||
(3) | A derivative, quasi-derivative or stock lending transaction is only admissible for the purposes of paragraph (1) above if it falls within paragraph (1)(A)(f), notwithstanding that it may also fall into one or more other categories in paragraph (1). |
- 01/04/2013
GENPRU 2 Annex 8
Guidance on applications for waivers relating to Implicit items
- 31/12/2006
See Notes
1 | The capital resources table does not permit implicit items to be included in the calculation of a firm'scapital resources, except subject to a waiver under section 138A of the Act. Article 27(4) of the Consolidated Life Directive states that implicit items can be included in the calculation of a firm'scapital resources, within limits, provided that the supervisory authority agrees. Certain implicit items, however, are not eligible for inclusion beyond 31 December 2009 (see paragraph 5). The PRA may be to grant a waiver from the capital resources table to allow implicit items, in line with the purpose of the Consolidated Life Directive, and provided the conditions as set out in article 27(4) of the Consolidated Life Directive are met. Such a waiver would allow an implicit item to count towards the firm'scapital resources available to count against its capital resources requirement (CRR) set out for realistic basis life firms in GENPRU 2.1.18 R and for regulatory basis only life firms in GENPRU 2.1.23 R. An implicit item may potentially count as tier one capital (but not core tier one capital) or tier two capital. Where a waiver is granted allowing an implicit item as tier one capital, the value of the implicit item so allowed must be included at stage B of the capital resources table. If the application of the value of the implicit item is restricted by GENPRU 2.2.29 R, which requires that at least 50% of a firm'stier one capital resources must be accounted for by core tier one capital, the remainder may be included at stage G of the calculation in the capital resources table, subject to GENPRU 2.2.31 G. An implicit item treated as tier two capital will also be included at stage G of the calculation, again subject to GENPRU 2.2.81 R. Article 29(1) of the Consolidated Life Directive requires that implicit items be excluded from the capital eligible to cover the guarantee fund. Under GENPRU 2.2.33 R a firm must meet the guarantee fund from the sum of the items listed at stages A, B, G and H of the capital resources table less the sum of the items listed at stage E of the capital resources table. The PRA will only grant an implicit itemswaiver if the waiver includes a modification to GENPRU 2.2.33 R to ensure that the implicit item does not count towards meeting the guarantee fund. | |
2 | Under section 138A of the Act, the PRA may, on the application of a firm, grant a waiver. There are general requirements that must be met before any waiver can be granted. The PRA may not give a waiver unless the PRA is satisfied that: | |
(1) | compliance by the firm with the rules will be unduly burdensome, or would not achieve the purpose for which the rules were made; and | |
(2) | the waiver would adversely affect the advancement of any of the appropriate regulator's objectives | |
3 | The appropriate regulator PRA will assess compliance with the requirements in the light of all the relevant circumstances. This will include consideration of the costs incurred by compliance with a particular rule or whether a rule is framed in a way that would make compliance difficult in view of the firm's circumstances. For example, the firm may demonstrate that if an implicit item were not allowed, the firm would either have to suffer increased (and unwarranted) costs in injecting further capital resources or operate with a lower equity backing ratio (see case studies in paragraph 43). Even if a firm can demonstrate a case for an implicit item waiver, it should not assume that the appropriate regulator PRA will grant the waiver requested, or that any waiver will be granted for the full amount of the implicit item which could be granted, as set out in this annex. The appropriate regulator PRA will consider each application on its own merits, and taking into account all relevant circumstances, including the financial situation and business prospects of the firm. | |
4 | Implicit items are economic reserves which are contained within the long-term insurance business provisions. Article 27(4) of the Consolidated Life Directive identifies three types of implicit item, in respect of: future profits, zillmerisation and hidden reserves. This annex is intended to provide guidance relating to the granting of waivers for implicit items and to provide guidance on other aspects. Whilst this guidance applies to applications for waivers for implicit items generally, for a realistic basis life firm, to the extent that an implicit item is allocated to a with-profits fund, this guidance relates to implicit items for the purposes of determining the regulatory value of assets (see INSPRU 1.4.24 R). | |
5 | The Consolidated Life Directive (reflecting the changes introduced by the Solvency 1 Directive) requires member states to end a firm's ability to take into account future profits implicit items by (at the latest) 31 December 2009. Until then, the maximum amount of the implicit item relating to future profits permitted under the Consolidated Life Directive is limited to 50% of the product of the estimated annual profits and the average period to run (not exceeding six years) on the policies in the portfolio. The Consolidated Life Directive further limits the maximum amount of these economic reserves that can be counted to 25% of the lesser of the available solvency margin and the required solvency margin. The changes introduced by the Solvency 1 Directive take effect for financial years beginning on or after 1 January 2004. However, the Consolidated Life Directive allows for a transitional period of five years, which runs from 20 March 2002 (the publication date of the Solvency 1 Directive), for Firms to become fully compliant with these new requirements. Firms will need to consider the potential impact of these changes when engaging in future capital planning. When applying for an implicit item waiver a firm should provide the PRA with a plan showing how the firm intends to maintain its capital adequacy over the period to 31 December 2009. firms Firms should also be aware that the PRA will typically only grant waivers for a maximum of 12 months. | |
Future Profits | ||
6 | The future profits implicit item allows firms to take credit for margins in the mathematical reserves to the extent that these are expected to emerge from in force business. The future profit from in force business should be assessed, in the first instance, on prudent assumptions, to demonstrate that there is an 'economic reserve'. Having demonstrated that it exists, the amount should be limited to an amount calculated using a formula that takes into account the actual profit which has emerged over the last five years (see paragraph 28). | |
Zillmerisation | ||
7 | Zillmerisation is an allowance for acquisition costs that are expected, under prudent assumptions, to be recoverable from future premiums. Firms can make a direct adjustment to their reserves for zillmerisation, subject to the rules on mathematical reserves. However, where no such adjustment has been made, the PRA will consider an application for a waiver to take into account an implicit item. | |
Hidden reserves | ||
8 | Hidden reserves are reserves resulting from the underestimation of assets (other than mathematical reserves). | |
Process for applying for a waiver, including limits applicable when a waiver is granted | ||
9 | This annex sets out the procedures to be followed and the form of calculations and data which should be submitted by firms to the PRA . This guidance should also be read in conjunction with the general requirements relating to the waiver process. The PRA expects that applications for waivers in respect of future profits and zillmerising will not normally be considered to pass the "would not adversely affect the advancement of any of the PRA's objectives" test unless the relevant criteria set out in this guidance have been satisfied and an application for such a waiver may require further criteria to be satisfied for this test to be passed. As set out below, waivers in respect of either zillmerising or hidden reserves will not normally be given except in very exceptional circumstances. | |
Timing | ||
10 | A long-term insurer may apply to the PRA for a waiver in respect of implicit items. A waiver will not apply retrospectively. Consequently, applications intended for a particular accounting reference date will normally need to be made well before that reference date. Applications by firms must be made to the PRA in writing and include the relevant details specified under Permissions and Waivers 4 in the PRA Rulebook. Given the uncertainty in predicting the future, waivers will normally be granted for a maximum of 12 months at a time and any further applications will need to be made accordingly. | |
11 | The information that will be required to enable an application to be considered as set out below, should normally include a demonstration of how the capital resources requirement is to be met, with and without the waiver. Clearly, up-to-date information may not be available before the financial year-end. In some cases information from the previous year-end's return may be used, as long as any known significant changes in the structure of the firm, or the assumptions used, have been taken into account. | |
12 | If the application for a waiver is granted, when a firm submits its next return the amount of the implicit item shown should not exceed that supported by the firm's calculations as at the valuation date. In the event that the amount of the future profits item calculated by the firm based on these updated assumptions is less than the amount calculated at the time of the firm'swaiver application, the lower figure should be used in the return. | |
13 | An implicit item waiver in respect of zillmerising or hidden reserves is related to the basis on which liabilities or assets have been valued. In the case of hidden reserves, as explained below, the granting of a waiver will be dependent on the overall capital resources of the firm. Waivers in respect of these implicit items will, therefore, only be made in relation to the position shown in a particular set of returns and it will be essential for firms to submit applications to the appropriate regulator PRA well in advance of the latest date for the submission of the relevant return. | |
14 | Waivers may be withdrawn by the PRA at any time (e.g. where the PRA considers the amount in respect of which a waiver has been given can no longer be justified). This may be as a result of changes in the firm's position or as a result of queries arising on scrutiny of the returns. | |
Information to be submitted | ||
15 | An application for a capital resources waiver (which includes an application for an extension to or other variation of a waiver) should be prepared using the standard application form for a waiver. In addition, the application should be accompanied by full supporting information to enable the PRA to arrive at a decision on the merits of the case. In particular, the application should state clearly the nature and the amounts of the implicit items that a firm wishes to count against its capital resources requirement and whether it proposes to treat the implicit item as tier one capital or tier two capital. In order to assess an application, the PRA needs information as to the make-up of the firm'scapital resources, the quality of the capital items which have been categorised into each tier of capital and a breakdown of capital both within and outside the firm'slong-term insurance fund or funds and between the firm'swith-profits funds and non-profit funds. An explanation as to the appropriateness of the proposed treatment of the implicit item under the capital resources table should also be provided, including a demonstration that, in allowing for implicit items, there has been no double counting of future margins and that the basis for valuing such margins is prudent. | |
16 | The PRA recognises that the assessment of the insurance technical provisions reflects the contractual obligations of the firm. Implicit items are therefore margins over and above an economic assessment in these technical provisions only. Non-contractual "constructive" obligations arising from a firm's regulatory duty (as regulated by theFCA) to treat customers fairly e.g. regarding future terminal bonuses, are not fully captured by the technical provisions. A firm must instead be satisfied that it has sufficient capital resources at all times to meet its obligations under the FCA'sPrinciple 6. The granting of a waiver for an implicit item does not in any way detract from this requirement and a firm will need to be satisfied that this condition is still met. | |
17 | As a minimum, applications for a future profits implicit item waiver should be supported by the information contained in Forms 13, 14, 18, 19, 40, 41, 42, 48, 49, the answers to questions 1 to 12 of the abstract of the valuation report, Appendix 9.4 of IPRU(INS), the abstract of the valuation report for the realistic valuation, Appendix 9.4A of IPRU(INS) and Forms 51, 52, 53, 54 and 58. For a zillmerisation implicit item waiver , only those items noted above forming part of the abstract valuation report will normally be needed. Applications for a waiver in respect of a hidden reserves implicit item will normally be considered only if accompanied by the information which is contained in the annual regulatory returns. In particular, the balance sheet forms, long-term insurance business revenue accounts, and abstract of the valuation report as set out in Appendices 9.1, 9.3 and 9.4 of IPRU(INS) should be provided. This is not to say that a full regulatory return must be provided in the specified format, simply that the information contained in these forms should be provided. Where appropriate, the information may be summarised. | |
18 | The following supporting information relating to the calculation of the amounts claimed should be supplied for each type of implicit item in respect of which a waiver is sought: Future profits: in addition to information related to the prospective calculation and retrospective calculation described below, the profits reported in each of the last five financial years up to the date of the most recent available valuation under rule 9.4 of IPRU(INS) which has been submitted to the PRA prior to, or together with, the application, and the amounts and nature of any exceptional items left out of account; the method used for calculating the average period to run and the results for each of the main categories of business, both before and after allowing for premature termination (where the calculation has been made in two stages); and the basis on which this allowance has been made. Zillmerising: the categories of contracts for which an item has been calculated and the percentages of the relevant capital sum in respect of which an adjustment has been made. Hidden reserves: particulars, with supporting evidence, of the undervaluation of assets for which recognition is sought. | |
Continuous monitoring by firms | ||
19 | Firms should take into account any material changes in financial conditions or other relevant circumstances that may have an impact on the level of future profits that can prudently be taken into account. Firms should also re-evaluate whether an application to vary an implicit item waiver should be made whenever circumstances have changed. In the event that circumstances have changed such that an amendment is appropriate, the firm must contact the PRA as quickly as possible in accordance with Fundamental Rule 7. In this context, the PRA would expect notice of any matter that materially impacts on the firm's financial condition, or any waivers granted. | |
Future profits - factors to take into account when submitting calculations to support waiver applications | ||
20 | Where an application is made in respect of a firm which has separate with-profits funds and non-profit funds, the firm should ensure that the capital resources requirement in respect of the non-profit fund is not covered by future profits attributable to policyholders arising in the with-profits fund. Furthermore, for a realistic basis life firm the amount of the implicit item allocated to each with-profits fund should be calculated separately, as the amount allocated to each with-profits fund will be taken into consideration in the calculation of the with-profits insurance capital component (see INSPRU 1.4.24 R). | |
21 | Firms need to assess prospective future profit (i.e. how much can reasonably be expected to arise) and compare this to maximum limits (in article 27(4) of the Consolidated Life Directive), which relate to past profits. | |
Future profits - prospective calculation | ||
22 | The application for a waiver should be supported by details of a prospective calculation of future profits arising from in-force business. The information supplied to the PRA should include a description of the method used in the calculation and of the assumptions made, together with the results arising. From 31 December 2009 at the latest, future profits implicit items will no longer be permitted under the Consolidated Life Directive. Where a firm first applies for an implicit item waiver after GENPRU 2.2 comes into effect, under the prospective calculation a firm should only take into consideration future profits that are expected to emerge in the period up to 31 December 2009. Implicit item waivers granted before GENPRU 2.2 comes into effect will continue to operate under the terms of those waivers, but an application to vary the terms of such a waiver, for example to extend the effective period, is an application for a new waiver for which a firm should usually only take into consideration future profits that are expected to emerge in the period up to 31 December 2009. | |
Assumptions | ||
23 | The assumptions made should be prudent, rather than best estimate, assumptions of future experience (that is, the prudent assumptions should allow for the fair market price for assuming that risk including associated expenses). In particular, it would not normally be considered appropriate for the projected return on any asset to be taken to be higher than the risk-free yield (that is, assessed by reference to the yield arrived at using a model of future risk free yields properly calibrated from the forward gilts market). It may also be appropriate to bring future withdrawals into account on a suitably prudent basis. For with-profits business, the assumptions for future investment returns should not capitalise future bonus loadings except where the with-profits policyholders share in risks other than the investment performance of the fund. Furthermore, the rate at which future profits are discounted should include an appropriate margin over a risk free rate of return. Calculations should also be carried out to demonstrate that the prospective calculation of the future profits arising from the in-force business supporting the application for the implicit item waiver would be sufficient to support the amount of the implicit item under each scenario described for use in determining the resilience capital requirement - where the waiver relates to an implicit item allocated to more than one fund, this should be demonstrated separately for that element of the implicit item allocated to each fund. For an implicit item allocated to a with-profits fund, proper allowance should be made for any shareholder transfers to ensure that the implicit item is not supported by future profits which will be required to support those transfers. To the extent, if any, that future profits are dependent on the levying of explicit expense related charges (for example as in the case of unit-linked business) the documentation submitted should include a demonstration of the prudence of the assumptions made as to the level at which future charges will be levied and expenses incurred. | |
Other limitations on the extent to which waivers for implicit items will be granted to a realistic basis life firm | ||
24 | Where a waiver in respect of an implicit item is granted to a realistic basis life firm additional limits may apply by reference to a comparison of realistic excess capital and regulatory excess capital including allowance for the effect of the waiver. Where the capital resources waiver relates to an implicit item allocated partly or entirely to a with-profits fund, the waiver will contain a limitation to the effect that the regulatory excess capital for that with-profits fund, allowing for the effect of the waiver, may not exceed that fund's realistic excess capital. This limitation will apply on an ongoing basis so that, for example, in the case of an implicit item allocated to a with-profits fund, the amount of the implicit item would be limited to zero whenever the regulatory excess capital exceeded the realistic excess capital of that fund. | |
Other charges to future profits | ||
25 | To avoid double counting, no account should be taken of any future surplus arising from assets corresponding to explicit items which have been counted towards the capital resources requirement such as shareholders funds, surplus carried forward or investment reserves. Deductions should be made in the calculation of future surpluses for the impact of any other arrangements which give rise to a charge over future surplus emerging (e.g. financial reinsurance arrangements, subordinated loan capital or contingent loan agreements). Deductions should also be made to the extent that any credit has been taken for the purposes of INSPRU 1.4.45 R (2) for the present value of future profits relating to non-profit business written in a non-profit fund. The information supplied to the PRA should identify the amount and reason for any adjustments made to the calculation of the prospective amount of future profits. | |
26 | The firm should confirm to the PRA that the calculations have been properly carried out and that there are no other factors that should be taken into account. | |
Future profits - retrospective calculation | ||
Overriding limit | ||
27 | The maximum amount of the implicit item relating to future profits permitted under the Consolidated Life Directive is 50% of the product of the estimated annual profit and the average period to run (not exceeding six years (ten years during the transitional period referred to in paragraph 5)) on the policies in the portfolio. Article 27(4) of the Consolidated Life Directive also imposes a further limit on the amount of the implicit item equal to 25% of the lower of: | |
(1) | the firm'scapital resources; and | |
(2) | the higher of its base capital resources requirement for long-term insurance business and its long-term insurance capital requirement. | |
Once the transitional period set out in article 71(1) of the Consolidated Life Directive has expired in 2007 (see paragraph 5), the appropriate regulator will not allow a capital resources for more than the amount permitted by article 27(4) of the Directive. | ||
Definition of profits | ||
28 | The estimated annual profit should be taken as the average annual surplus arising in the long-term insurance fund over the last five financial years up to the date of the most recent available valuation which has been submitted to the PRA prior to, or together with, the application. For this purpose, deficiencies arising should be treated as negative surpluses. Where a firm'sfinancial year has altered, the surplus arising in a period falling partly outside the relevant five year period should be assumed to accrue uniformly over the period in question for the purpose of estimating the profits arising within the five year period. When there has been a transfer of a block of business into the firm (or out of the firm) during the period, surplus arising from the transferred block should be included (or excluded) for the full five year period. Where a portion of a block of business is transferred, the surplus included (or excluded) should be a reasonable estimate of the surplus arising from the portion transferred. | |
29 | Where a firm has been carrying on long-term insurance business for less than 5 years, the total profits made during the past five years should be taken to be the aggregate of any surpluses that have arisen during the period in which long-term insurance business has been carried on less any deficiencies that may have arisen during that period. The resulting total should still be divided by five to obtain the estimated annual profit. | |
Exceptional items | ||
30 | Substantial items of an exceptional nature should be excluded from the calculation of the estimated annual profit. Such items include profits arising from an exceptional change in the value at which assets are brought into account, where this is not reflected in a similar change in the amount of the liabilities, and profits arising from a change in the overall valuation approach between one year and another. An exceptional loss (i.e. a reduction of an exceptional nature in the surplus arising) may be excluded from the calculation only to the extent that it can be set against a profit or profits up to the amount of the loss and arising from a similar cause. It is not intended, however, that any adjustment should be made for the effect on surplus of a net strengthening of reserves for costs associated with an expansion of the business or for special capital expenditure, such as the purchase of computer systems. | |
Double counting | ||
31 | The inclusion of investment income arising from the assets representing the explicit components of capital resources (as part of the estimated annual profit for the purpose of determining the future profits implicit item) would result in double-counting. If those assets were required to meet the effects of adverse developments, this would automatically result in the cessation of the contribution to profits from the associated investment income. It would clearly not be appropriate for the PRA to grant a capital resources waiver which would enable a firm to meet the capital resources requirement on the basis of counting both the capital values of the assets and the value of the income flow which they can be expected to generate. | |
32 | The definition of the estimated annual profit as the surplus arising in the long-term insurance fund ensures that any contribution to surplus arising from transfers from the profit and loss account, including investment income on shareholders' assets, is not included in the estimated annual profit. Thus double-counting should not arise in respect of shareholders' assets. Double-counting may arise, however, in respect of the investment income from the assets representing the explicit components of capital resources carried within the long-term insurance fund (e.g. surplus carried forward or investment reserves), but the amount of such investment income is not separately identified in the return. | |
33 | Where there is reason to suspect that the elimination of any such double-counting would reduce a firm'scapital resources to close to or below the required level, or would otherwise be significant, the PRA will request this information with a view to taking account of this factor in determining the amount of the implicit item. Additional information concerning investment income should be furnished with an application for a waiver, if a firm believes that any double-counting would fall into one of the categories mentioned above. | |
Average period to run | ||
34 | The average number of years remaining to run on policies should be calculated on the basis of the weighted average of the periods for individual contracts of insurance, using as weights the actuarial present value of the benefits payable under the contracts. A separate weighted average should be calculated for each of the various categories of contract and the results combined to obtain the weighted average for the portfolio as a whole. Approximate methods of calculation, which the firm considers will give results similar to the full calculation, will be accepted. In particular, the PRA will normally accept the calculation of an average period to run for a specific category of contract on the basis of the average valuation factor for future benefits derived from data contained in the abstract of the valuation report in the regulatory returns. A firm will be asked to demonstrate the validity of the method adopted only where an abnormal distribution of the business in force gives grounds for doubt about its accuracy. | |
35 | Calculations will normally be requested only for the main categories of insurance business, accounting for not less than 90% of the mathematical reserves, except where there are grounds for expecting that the exclusion of certain categories of policies under this provision might have a significant effect on the resulting average period to run. Detailed calculations will not be required where a waiver is sought in respect of a low multiple of the annual profits, well within the average period to run for the firm. | |
36 | Where, for a particular category of business, a method of valuation is used which does not involve the calculation of the value of future benefits and which is significant for the firm in question, the calculation of the average period to run should be based on estimates of the value of future benefits. | |
Premature termination of contracts | ||
37 | Allowance should be made for the premature termination of contracts of insurance, based on the actual experience of the firm over the last five years, or other appropriate period, and taking into account specific features of contracts such as options which can be expected to lead to premature termination (e.g. guaranteed surrender values on income bonds written as long-term insurance contracts and option dates on flexible whole-life contracts). The adjustment should be made separately for each of the main categories of business. The use of industry-wide rates of termination will be acceptable where a firm is satisfied that this will result in sufficient allowance being made having regard to the firm's own experience. Methods of calculation that involve a degree of approximation will be permitted. | |
38 | For certain types of contract, where the period left to run is most naturally defined as the term to a fixed maturity or expiry date, the allowance for premature termination should also take into account terminations resulting from death. | |
Overall limit | ||
39 | The overall average period left to run calculated as described above should be limited to a maximum of six years under article 27(4) of the Consolidated Life Directive (or a maximum of ten years during the transitional period referred to in paragraph 5) before applying it to the estimated annual profit in order to determine the maximum value of the future profits implicit item. | |
Definition of period to run | ||
40 | The definition of the period to run and the basis of the allowance for early termination should clearly be considered together. For certain types of contracts (e.g. pension contracts with a range of retirement ages or other options), there is inherent uncertainty about the likely term to run. In such circumstances any estimate for determining the amount of the future profits implicit item for which a waiver is sought should be based on prudent assumptions tending, if anything, to underestimate the average period to run. | |
Zillmerising | ||
41 | The PRA does not normally expect to grant a waiverpermitting implicit items due to zillmerisation except in very exceptional circumstances. Zillmerisation is an allowance for acquisition costs that are expected, under prudent assumptions, to be recoverable from future premiums. Firms can make a direct adjustment to their reserves for zillmerisation, subject to the requirements on mathematical reserves set out in INSPRU 1.3.43 R, and this is the usual approach. However, where no such adjustment has been made, or where the maximum adjustment has not been made in the mathematical reserves, the PRA will consider an application for an implicit item waiver , if the amount is consistent with the amount that would have been allowed as an adjustment to mathematical reserves under INSPRU 1.3.43 R. | |
Hidden reserves | ||
42 | The PRA will grant waivers permitting implicit items due to hidden reserves only in very exceptional circumstances. These items relate to hidden reserves resulting from the underestimation of assets. The rules for the valuation of assets and liabilities (see GENPRU 1.3) which apply to assets and liabilities other than mathematical reserves are based on the valuation used by the firm for the purposes of its external accounts, with adjustments for regulatory prudence such as concentration limits for large holdings, and would not normally be expected to contain hidden reserves. | |
Case studies on "unduly burdensome" | ||
43 | Some examples of situations where the existing rules might be considered to be unduly burdensome are given below: | |
• | A firm writes with-profits business. The firm's investment policy is affected by its published financial position. Application of the rules without an implicit item waiver would result in the firm adopting a lower equity backing ratio. It may be possible to demonstrate that, in the circumstances, it would be unduly burdensome to require the firm to incur costs (which might prejudice policyholders) resulting from the lower equity backing ratio, rather than take allowance for an implicit item. | |
• | A firm has purchased a block of in-force business, on which the future profits may be reasonably estimated. However, this asset is given no value under the rules. It may be possible to demonstrate that it is unduly burdensome for the firm to recognise the cost of acquiring the assets whilst giving no value to the asset acquired. | |
• | A firm has a block of in-force business, on which the future profits may be reasonably estimated. Application of the rules without an implicit item waiver would result in a need to obtain additional capital. It may be possible to demonstrate that it is unduly burdensome, having regard to the particular circumstances of the firm, to require it to incur the costs involved in the injection of further capital rather than take allowance for an implicit item. | |
• | A firm has purchased matching assets for guaranteed annuity liabilities. The operation of the asset and liability valuation rules leads to statutory losses in certain circumstances in spite of good matching of assets and liabilities on a realistic basis of assessment. It may be possible to demonstrate that it is unduly burdensome to require the firm to incur the costs involved in the injection of further capital rather than take allowance for an implicit item. | |
Conditions which will typically be applied to implicit items waivers | ||
Limits | ||
44 | Where implicit itemswaivers are granted, the value cannot exceed (and will normally be less than) the monetary limits described in paragraph 27, except that during the transitional period the pre-Solvency I limits will apply. In addition, time limits will apply and waivers will normally only last for 12 months. | |
Publicity | ||
45 | The PRA will publish the waiver. Public disclosure is standard practice unless the PRA is satisfied that publication is inappropriate or unnecessary (see section 138B of the Act). Any request that a direction not be published should be made to the PRA in writing with grounds in support. Disclosure of a waiver will normally be required in the firm's annual returns. |
- 19/06/2014